New hope for hemophilia: can SCT800 stop bleeds before they start?
NCT ID NCT07437404
First seen Feb 28, 2026 · Last updated May 05, 2026 · Updated 14 times
Summary
This study tests a new medicine called SCT800 in 36 men with severe hemophilia A who have never been treated with factor VIII before. The goal is to see if regular infusions of SCT800 can safely prevent bleeding episodes. Participants will receive the drug on a schedule and be monitored for side effects and how well it controls bleeds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing children's hospital
RECRUITINGBeijing, Beijing Municipality, 000000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.